NYSE:PRGO - Perrigo Stock Price, News, & Analysis

Perrigo trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRGO."

Perrigo announced a quarterly dividend on Wednesday, October 31st. Shareholders of record on Friday, November 30th will be given a dividend of $0.19 per share on Tuesday, December 18th. This represents a $0.76 dividend on an annualized basis and a dividend yield of 1.70%. The ex-dividend date of this dividend is Thursday, November 29th. View Perrigo's Dividend History.

Perrigo Company PLC (NYSE:PRGO) released its quarterly earnings data on Thursday, November, 8th. The company reported $1.09 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $1.05 by $0.04. The company earned $1.13 billion during the quarter, compared to analyst estimates of $1.17 billion. Perrigo had a net margin of 2.54% and a return on equity of 11.32%. The firm's quarterly revenue was down 8.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.39 earnings per share. View Perrigo's Earnings History.

Perrigo is scheduled to release their next quarterly earnings announcement on Thursday, March 7th 2019. View Earnings Estimates for Perrigo.

Perrigo issued an update on its FY18 earnings guidance on Thursday, November, 8th. The company provided earnings per share (EPS) guidance of $4.45-4.65 for the period, compared to the Thomson Reuters consensus estimate of $4.86. The company issued revenue guidance of ~$4.72 billion, compared to the consensus revenue estimate of $4.87 billion.Perrigo also updated its FY 2018 guidance to $4.45-4.65 EPS.

13 Wall Street analysts have issued 1-year target prices for Perrigo's shares. Their predictions range from $46.00 to $110.00. On average, they anticipate Perrigo's share price to reach $77.3571 in the next twelve months. This suggests a possible upside of 72.6% from the stock's current price. View Analyst Price Targets for Perrigo.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Perrigo in the last year. There are currently 1 sell rating, 10 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Perrigo.

Media stories about PRGO stock have trended very positive on Tuesday, according to InfoTrie Sentiment. The research group ranks the sentiment of press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Perrigo earned a news impact score of 3.2 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 4.0 out of 10, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next several days.

Perrigo saw a decline in short interest during the month of December. As of December 31st, there was short interest totalling 5,474,515 shares, a decline of 37.7% from the December 14th total of 8,791,586 shares. Based on an average daily trading volume, of 3,537,573 shares, the short-interest ratio is currently 1.5 days. Currently, 4.0% of the shares of the stock are sold short. View Perrigo's Current Options Chain.

Some companies that are related to Perrigo include Shiseido (SSDOY), Teva Pharmaceutical Industries (TEVA), BioMarin Pharmaceutical (BMRN), UCB (UCBJF), Mylan (MYL), Ono Pharmaceutical (OPHLF), GRIFOLS S A/S (GRFS), Merck KGaA (MKGAF), Genmab A/S (GNMSF), Beigene (BGNE), Alnylam Pharmaceuticals (ALNY), Sarepta Therapeutics (SRPT), Bausch Health Companies (BHC), Nektar Therapeutics (NKTR) and Ionis Pharmaceuticals (IONS).

Perrigo's stock is owned by a variety of of institutional and retail investors. Top institutional investors include GW Henssler & Associates Ltd. (0.05%), Nippon Life Global Investors Americas Inc. (0.03%), State of Alaska Department of Revenue (0.03%), Nisa Investment Advisors LLC (0.02%), Moon Capital Management LLC (0.02%) and Meeder Asset Management Inc. (0.02%). Company insiders that own Perrigo stock include Geoffrey M Parker, Jeffrey C Smith, Jeffrey Needham, John Wesolowski, Murray S Kessler, Sharon Kochan, Svend Andersen, Thomas Farrington, Todd W Kingma and Uwe Roehrhoff. View Institutional Ownership Trends for Perrigo.

PRGO stock was sold by a variety of institutional investors in the last quarter, including Moon Capital Management LLC, GW Henssler & Associates Ltd. and Louisiana State Employees Retirement System. View Insider Buying and Selling for Perrigo.

PRGO stock was purchased by a variety of institutional investors in the last quarter, including Meeder Asset Management Inc., Nippon Life Global Investors Americas Inc., State of Alaska Department of Revenue and Nisa Investment Advisors LLC. Company insiders that have bought Perrigo stock in the last two years include Geoffrey M Parker, Jeffrey C Smith, John Wesolowski, Murray S Kessler, Svend Andersen, Todd W Kingma and Uwe Roehrhoff. View Insider Buying and Selling for Perrigo.

Shares of PRGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of PRGO stock can currently be purchased for approximately $44.82.

Perrigo has a market capitalization of $6.25 billion and generates $4.95 billion in revenue each year. The company earns $119.60 million in net income (profit) each year or $4.93 on an earnings per share basis. Perrigo employs 10,400 workers across the globe.

The official website for Perrigo is http://www.perrigo.com.

Perrigo's mailing address is TREASURY BUILDING LOWER GRAND CANAL STREET, DUBLIN L2, 49010. The company can be reached via phone at 353-1709-4000 or via email at [email protected]